Is mycobacterial heat shock protein 16kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen?

Human Immunology

Volumn 74, Issue 1, 2013, Pages 45-51

  Dubaniewicz, Anna ^a   Holownia, Adam ^b   Kalinowski, Leszek ^a   Wybieralska, Monika ^a   Dobrucki, Iwona T ^c   Singh, Mahavir ^d,e  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 16; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; MYCOBACTERIUM ANTIGEN; NITRATE; NITRITE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DORMANCY; FEMALE; HUMAN; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SARCOIDOSIS; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHAPERONIN 60; FEMALE; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; SARCOIDOSIS, PULMONARY; TUBERCULOSIS, PULMONARY;

EID: 84870914880     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.007     Document Type: Article

References (49)

1. American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736-55.
2. Chen E.S., Moller D.R. Etiology of sarcoidosis. Clin Chest Med 2008, 29:365-377.
3. Dubaniewicz A. Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun Rev 2010, 9:419-424.
4. Dubaniewicz A., Dubaniewicz-Wybieralska M., Sternau A., Zwolska Z., Izycka-Swieszewska E., Augustynowicz-Kopec E., et al. Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 2006, 44:3448-3451.
5. Dubaniewicz A., Kämpfer S., Singh M. Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis. Tuberculosis (Edinb) 2006, 86:60-67.
6. Oswald-Richter K.A., Beachboard D.C., Zhan X., Gaskill C.F., Abraham S., Jenkins C., et al. Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir Res 2010, 11:161.
7. Ang S.C., Moscovitz E.A. Cross-react and species specific Mycobacterium tuberculosis antigens in the immunoprofile of Schaumann bodies: a major clue to the etiology sarcoidosis. Histol Histopathol 1996, 11:125-134.
8. Zügel U., Kaufmann S.H.E. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999, 12:19-39.
9. Valdez M.M., Clark J.I., Wu G.J.S., Muchowski P.J. Functional similarities between the small heat shock proteins Mycobacterium tuberculosis HSP16.3 and human α B-crystallin. Eur J Biochem 2002, 269:1806-1813.
10. Blank M., Barzilai O., Shoenfeld Y. Molecular mimicry and autoimmunity. Clin Rev Allergy Immunol 2007, 32:111-118.
11. Wendling U., Liesbeth P., van der Zee R., Prakken B., Singh M., van Eden W. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol 2000, 164:2711-2717.
12. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity - friends or foes?. Trends Immunol 2009, 30:409-414.
13. Rajaiah R., Moudgil K.D. Heat shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 2009, 8:388-393.
14. Shoenfeld Y., Gilburd B., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr Med Assoc J 2008, 10:3-7.
15. Dubaniewicz A., Jamieson S.E., Dubaniewicz-Wybieralska M., Fakiola M., Miller N.E., Blackwell J.M. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Gen 2005, 13:829-834.
16. Dubaniewicz A., Dubaniewicz-Wybieralska M., Moszkowska G., Sternau A., Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:180-189.
17. Dubaniewicz A., Trzonkowski P., Dubaniewicz-Wybieralska M., Dubaniewicz A., Singh M., Myśliwski A. Comparative analysis of mycobacterial heat shock proteins-induced apoptosis of peripheral blood mononuclear cells in sarcoidosis and tuberculosis. J Clin Immunol 2006, 26:243-250.
18. Dubaniewicz A., Trzonkowski P., Dubaniewicz-Wybieralska M., Dubaniewicz A., Singh M., Myśliwski A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 2007, 12:346-354.
19. Raja A., Uma Devi K.R., Ramalingam B., Brennan P.J. Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16kDa antigen of Mycobacterium tuberculosis. Clin Diagn Lab Immunol 2002, 9:308-312.
20. Jee B., Katoch V.M., Awasthi S.K. Dissection of relationship between small heat shock proteins and mycobacterial diseases. Indian J Lepr 2008, 80:231-245.
21. Cunningham A.F., Spreadbury C.L. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16kDa alpha-crystallin homolog. J Bacteriol 1998, 180:801-808.
22. Wayne L.G. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 1994, 13:908-914.
23. Simpson R.M., Zhu Y.Q., Hickey M.J., Sherman D.R., Barry C.E. The 16kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci USA 1998, 95:9578-9583.
24. Voskuil M.I., Schnappinger D., Visconti K.C., Harrell M.I., Dolganov G.M., Sherman D.R., et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tubrculosis dormancy program. J Exp Med 2003, 198:705-713.
25. Garbe T.R., Hibler N.S., Deretic V. Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16kDa α-crystallin homolog by exposure to nitric oxide donors. Infect Immun 1999, 67:460-465.
26. Booth R.J., Williams D.L., Moudgil K.D., Noonan L.C., Grandison P.M., McKee J.J., et al. Homologs of Mycobacterium leprae 18-kilodalton and Mycobacterium tuberculosis 19kDa antigens in other mycobacteria. Infect Immun 1993, 61:1509-1515.
27. + when the Griess reaction is used to assay for nitrite. Annal Biochem 1995, 224:502-508.
28. Arrigo A.P. Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 1998, 379:19-26.
29. Mehlen P., Briolay J., Smith I., Diaz-Latoud C., Fabre N., Pauli D., et al. Analysis of the resistance to heat and hydrogen peroxide stresses in COS cells transiently expressing wild type or deletion mutants of the Drosophila 27kDa heat-shock protein. Eur J Biochem 1993, 215:277-284.
30. Rojas M., Barrera L.F., Puzo G., Garcia L.F. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J Immunol 1997, 159:1352-1361.
31. Mulvey M.R., Switala J., Borys A., Loewen P.C. Regulation of transcription of katE and katF in Escherichia coli. J Bacteriol 1990, 172:6713-6720.
32. Gordillo S., Guirado E., Gil O., Díaz J., Amat I., Molinos S., et al. Usefulness of acr expression for monitoring latent Mycobacterium tuberculosis bacilli in 'in vitro' and 'in vivo' experimental models. Scand J Immunol 2006, 64:30-39.
33. Brüggemann H., Henne A., Höster F., Liesegang H., Wiezer A., Strittmatter A., et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004, 305:671-673.
34. Farrar M.D., Ingham E., Holland K.T. Heat shock proteins and inflammatory acne vulgaris: molecular cloning, overexpression and purification of a Propionibacterium acnes, GroEL and DnaK homologue. FEMS Microbiol Lett 2000, 91:183-186.
35. Cardona P.J., Ruiz-Manzano J. On the nature of Mycobacterium tuberculosis-latent bacilli. Eur Respir J 2004, 24:1044-1051.
36. Preneta R., Papavinasasundaram K.G., Cozzone A.J., Duclos B. Autophosphorylation of the 16kDa and 70kDa antigens (Hsp 16.3 and Hsp 70) of Mycobacterium tuberculosis. Microbiology 2004, 150:2135-2141.
37. Dobrucki L.W., Marsh B.J., Kalinowski L. Elucidating structure-function relationships from molecule-to-cell-to-tissue: from research modalities to clinical realities. J Physiol Pharmacol 2009, 60:83-93.
38. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424.
39. Dubaniewicz A. Frequency of occurrence of circulating immune complexes in sera of patients with pulmonary sarcoidosis; Preliminary report. The Bull Interregion Clinical-Diagnostic Center 2004, III:108-113.
40. Schoenfeld N., Schmolke B., Schmitt M., Remy N., Ellensohn P., Wahn U., et al. Specification and quantitation of circulating immune complexes in the serum of patients with active pulmonary sarcoidosis. Thorax 1994, 49:688-691.
41. Dubaniewicz A., Typiak M., Wybieralska M., Szadurska M., Nowakowski S., Staniewicz-Panasik A., et al. Changed phagocytic activity and pattern of Fcγ and complement receptors on blood monocytes in sarcoidosis. Hum Immunol 2012, 73:788-794.
42. Spector W.G., Hessom N. The production of granulomata by antigen-antibody complexes. J Path 1969, 98:31-39.
43. Bonney R.J., Wightman P.D., Davies P., Humes J.L. Immune complexes cause the synthesis and release of lysosomal acid hydrolysis from macrophages. Eur J Rheumatol Inflamm 1979, 2:230.
44. Montaldo C., Cannas E., Ledda M., Rosetti L., Congiu L., Atzori L. Bronchoalveolar glutathione and nitrite/nitrate in idiopathic pulmonary fibrosis and sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002, 19:54-58.
45. O'Donnell D.M., Moynihan J., Finlay G.A., Keatings V.M., O'Connor C.M., McLoughlin P., et al. Exhaled nitric oxide and bronchoalveolar lavage nitrite/nitrate in active pulmonary sarcoidosis. Am J Respir Crit Care Med 1997, 156:1892-1896.
46. Choi J., Hoffman L.A., Sethi J.M., Zullo T.G., Gibson K.F. Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study. Sarcoidosis Vasc Diffuse Lung Dis 2009, 26:98-109.
47. Wilsher M.L., Fergusson W., Milne D., Wells A.U. Exhaled nitric oxide in sarcoidosis. Thorax 2005, 60:967-970.
48. Ziora D., Kaluska K., Kozielski J. An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis. Eur Respir J 2004, 24:609-614.
49. Moodley Y.P., Chetty R., Lalloo U.G. Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis. Eur Respir J 1999, 14:822-827.